Aniracetam
Aliases: Sarpul, Sarple, Ampamet, Referan, Draganon
Categories
Summary
Fat-soluble compound requiring dietary fat for optimal absorption. Oral bioavailability of parent drug is very low (~10%); most central activity believed to come from active metabolites (notably N-anisoyl-GABA and 2-pyrrolidinone). Users often stack with choline sources (CDP-choline, alpha-GPC) to reduce racetam-type headaches, though clinical necessity is unproven. Produces mild anxiolysis in some users without cognitive dulling. Not approved by U.S.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 500-1200mg | 1200-1800mg | 1800-2400mg | 2400mg+ |
| Sublingual | 500-1200mg | 1200-1800mg | 1800-2400mg | 2400mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Oral | 20-90 min | 30-60 min | 1-2 hrs | 1-2 hrs | 1-4 hrs | 120-0 min |
| Sublingual | 5-30 min | 15-30 min | 1-2 hrs | 1-2 hrs | 1-4 hrs | 120-0 min |
Tolerance
Build-up
develops over 1–4 weeks of regular use
Reset
days to weeks depending on duration of use
Effects
Positive
- Creativity enhancement
- Stimulation
- Stamina enhancement
- Mild stimulation
Negative
- Motor impairment
- Increased heart rate
- Headaches
- Insomnia
- Headache
- Sedation
Positive
- Anxiety suppression
- Focus enhancement
- Memory enhancement
- Motivation enhancement
- Thought connectivity
- Analysis enhancement
- Mindfulness
- Wakefulness
- Dream potentiation
Negative
- Irritability
Positive
- Color enhancement
- Visual acuity enhancement
- Music enhancement
- Auditory acuity enhancement
- Acuity enhancement
- Auditory enhancement
- Colour enhancement
- Tactile enhancement
Negative
- Light sensitivity
- Dulled perception